Mydecine Innovations Group Inc. announced that Larry Dean Ditto has resigned as Chief Financial Officer of the Company, for personal reasons. Mr. Ditto's resignation will be effective as of August 19, 2022. The Company has appointed Damon Michaels, the Company's chief operating officer, to serve as interim chief financial officer until such time as a suitable replacement for Mr. Ditto is appointed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0221 USD | +72.58% | +76.80% | +48.32% |
Feb. 23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
Feb. 02 | Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director | CI |
1st Jan change | Capi. | |
---|---|---|
+48.32% | 1.36M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Announces CFO Changes